Interested? Check out the advert.
|
|
In the first instance the TrypanoGEN network will focus on human susceptibility to African trypanosomiasis, a neglected tropical disease of sub-Saharan Africa that claims the lives of tens of thousands of people every year. The disease, commonly known as 'Sleeping Sickness', affects some of the poorest areas of the world and impacts the economy of many developing countries. Despite its importance there are very few drugs available to treat the disease and drug resistance is spreading. There is a desperate need for new treatments and intervention strategies and the TrypanoGEN project is addressing these issues. In the future, the network will develop to include studies on other major vector-borne parasitic diseases such as leishmaniasis.
|